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Interaction of the Profilaggrin N-Terminal Domain
with Loricrin in Human Cultured Keratinocytes
and Epidermis
Kozo Yoneda1, Toshitaka Nakagawa2, Owen T. Lawrence3, Jessica Huard3, Toshio Demitsu4, Yasuo Kubota1
and Richard B. Presland3,5
The relationship between the two coexpressed differentiation markers, profilaggrin and loricrin, is not clear
right now. In this study, we explored the interaction of profilaggrin N-terminal domain (PND) with loricrin in
keratinocytes and epidermis. Confocal immunofluorescence microscopic analysis of human epidermis showed
that PND colocalized with loricrin. Loricrin nucleofected into HaCaT cells colocalized with PND in the nucleus
and cytoplasm. The PND localizes to both the nucleus and cytoplasm of epidermal granular layer cells.
Nucleofected PND also colocalized with keratin 10 (K10) in the nucleus and cytoplasm. Immunoelectron
microscopic analysis of human epidermis confirmed the findings in nucleofected keratinocytes. Yeast two-
hybrid assays showed that the B domain of human and mouse PND interacted with loricrin. The glutathione
S-transferase (GST) pull-down analysis using recombinant GST-PND revealed that PND interacted with loricrin
and K10. Knockdown of PND in an organotypic skin culture model caused loss of filaggrin expression and a
reduction in both the size and number of keratohyalin granules, as well as markedly reduced expression of
loricrin. Considering that expression of PND is closely linked to keratinocyte terminal differentiation, we
conclude that PND interacts with loricrin and K10 in vivo and that these interactions are likely to be relevant for
cornified envelope assembly and subsequent epidermal barrier formation.
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INTRODUCTION
The outermost layers of stratified squamous epithelia are
composed of mechanically tough dead cornified cells
(corneocytes), which are formed as a result of a complex
terminal differentiation program (Yoneda et al., 1992b;
Kalinin et al., 2001, 2002; Candi et al., 2005). Cornified
cells are devoid of all organelles and are encapsulated within
a highly specialized structure termed the cornified envelope
(CE). CE insolubility is due to disulfide bonding and cross-
linking by Ne-(g-glutamyl)lysine isopeptide bonds formed by
transglutaminases (EC2.3.2.13) (Steinert and Marekov, 1995,
1997; Yoneda et al., 1998).
Upon terminal differentiation of granular cells, profilag-
grin is proteolytically cleaved into B37-kDa filaggrin
peptides and B32-kDa profilaggrin N-terminal domain
(PND) containing the S100-like calcium-binding domain
(Presland et al., 1995; Dale et al., 1997; Kuechle et al., 1999;
Pearton et al., 2001, 2002; Sandilands et al., 2009). The
human PND comprises two distinct domains: an acidic
A domain of 81 amino acids that binds Ca2þ and a cationic B
domain of 212 residues (Presland et al., 1992, 1997). The
A domain contains two calcium-binding motifs that are
similar to the EF-hands of the S100 family of calcium-
binding proteins and is able to bind calcium in vitro
(Presland et al., 1995). The B domain is 212 amino acids
in length, contains a high proportion of polar amino acids,
and is predicted to have a cationic net charge. We
previously raised five peptide antibodies directed to human
and mouse A and B domains (A1, A2, B1, B2, and Am1
antibodies; Presland et al., 1997; Pearton et al., 2002).
Using these antibodies we demonstrated that the PND was
cleaved from the filaggrin sequences during epidermal
differentiation and localized to the nucleus of dying
transition cells, which suggested that PND might have an
independent fate and/or function from filaggrin (Ishida-
Yamamoto et al., 1998).
ORIGINAL ARTICLE
1206 Journal of Investigative Dermatology (2012), Volume 132 & 2012 The Society for Investigative Dermatology
Received 15 June 2011; revised 23 October 2011; accepted 2 November
2011; published online 26 January 2012
1Department of Dermatology, Faculty of Medicine, Kagawa University,
Kagawa, Japan; 2Department of Life Science Research Center, Faculty of
Medicine, Kagawa University, Kagawa, Japan; 3Department of Oral Health
Sciences, University of Washington, Seattle, Washington, USA; 4Department
of Dermatology, Jichi Medical University, Saitama Medical Center, Saitama,
Japan and 5Division of Dermatology, Department of Medicine, University of
Washington, Seattle, Washington, USA
Correspondence: Kozo Yoneda, Department of Dermatology, Faculty of
Medicine, Kagawa University, 1750-1 Ikenobe, Kagawa 761-0793, Japan.
E-mail: kyoneda@med.kagawa-u.ac.jp
Abbreviations: 3-AT, 3-amino 1,2,4-triazole; cDNA, complementary DNA;
CE, cornified envelope; DAPI, 4,6-diamidino-2-phenylindole; GST,
glutathione S-transferase; K10, keratin 10; Lor, loricrin; PND, profilaggrin
N-terminal domain; siRNA, small interfering RNA; SPRR, small proline-rich
protein; Y2H, yeast two-hybrid
Loricrin (Latin: ‘‘lorica’’—a protective shell or cover)
functions as a key structural CE protein (Mehrel et al.,
1990; Hohl et al., 1991; Yoneda et al., 1992a, 1992b, 2010b;
Yoneda and Steinert, 1993). Loricrin is expressed in the
granular layer during cornification, and is unusually rich in
glycine, serine, and cysteine residues (Ishida-Yamamoto
et al., 1993, 1998). Loricrin is the chief component of the
epidermal CE comprising 70–85% of the total protein mass of
the CE.
In this paper, we report the colocalization of PND with
loricrin and keratin 10 (K10) in human epidermis and HaCaT
keratinocytes. We show that human PND interacts with
both loricrin and K10 using yeast two-hybrid (Y2H) assays
and immunoprecipitation of keratinocyte extracts. These
studies demonstrate the presence of a network of interactions
between CE and cytoskeletal proteins that are likely
important for building the CE and the resulting epidermal
permeability barrier.
RESULTS
The PND colocalizes with loricrin and K10 in epidermis and
HaCaT keratinocytes
Antibodies generated against the A and B PND domains
immunostained the cytoplasm of granular cells and the lower
cornified layers (Figure 1a and Supplementary Figure S1a
online). Filaggrin mAb AKH1 showed the typical particulate
pattern staining throughout the granular cells with some
staining of the stratum corneum (Figure 1a and Supplemen-
tary Figure S1a online).
To examine expression and colocalization of epitope-
tagged PND and loricrin peptides in cultured keratinocytes,
the PND construct pFLAG-467proF (Presland et al., 1997)
and loricrin-V5-His complementary DNAs (cDNAs) were
nucleofected into HaCaT cells. At 48 hours after nucleofec-
tion, HaCaT cells grown on glass coverslips were fixed with
methanol and immunolabeled with anti-V5 (to detect loricrin
peptide) or A2 or B1 profilaggrin antibodies (Figure 1b and
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Figure 1. Expression of the A and B domains of profilaggrin N-terminal domain (PND) in human adult epidermis and HaCaT cells and colocalization
with loricrin. (a) We prepared cryosections from optimal cutting temperature (OCT) compound–embedded normal human skin. We conducted double
immunostaining with filaggrin mAb AKH1 and A2 or B1 antibody. A2 and B1 immunostained cytoplasm of granular layers and also showed some reaction with
the lower stratum corneum. DAPI, 4,6-diamidino-2-phenylindole. Bars¼80 mm. (b) Distribution of PND in HaCaT cells nucleofected by pcDNA3.1/V5-His-
loricrin. Nucleofected HaCaT cells were fixed at 48 hours after transfection, and the cells were stained with anti-V5 antibody and either A2 or B1 antibody.
Nucleofected loricrin distributed diffusely in the cytoplasm and in the nuclei. PND also distributed in the nuclei abundantly and the cytoplasm in HaCaT cells. A
substantial portion of nucleofected loricrin colocalized with PND (arrows). Bars¼ 50mm. Interaction of PND and loricrin (Lor). (c) We doubly nucleofected
pFLAG467proF and pcDNA3.1/V5-His-loricrin into HaCaT cells. Cells were fixed at 48 hours after transfection, and the fate of the transfected gene product was
examined by double-label immunofluorescence. To visualize the nucleofected gene product, cells were doubly stained with a rabbit polyclonal antibody
recognizing the sequence of FLAG tag and a mouse mAb recognizing the sequence of V5 tag. PND distributed in the nuclei and diffusely in the cytoplasm in
nucleofected cells. PND and loricrin (Lor) colocalized not only in the cytoplasm but also in the nucleus (arrows). Bar¼ 25mm. We also doubly stained in vivo
human skin with B1 antibody and guinea pig polyclonal anti-loricrin antibody. PND and Lor colocalized in the cytoplasm of granular cells and the lower
cornified cells. Bars¼ 80mm. (d) We doubly stained HaCaT cells nucleofected with pFALG467proF with B1 antibody and mouse anti-K10 mAb. PND and
keratin 10 (K10) colocalized not only in the nucleus but also in the cytoplasm. Bar¼10 mm. We doubly stained in vivo human skin with B1 antibody
and mouse anti-K10 mAb. PND and K10 colocalized at granular layer and lower stratum corneum. We doubly stained Lor/ mouse skin with B1 antibody
and mouse anti-K10 mAb. PND and K10 colocalized at granular layer and lower stratum corneum. Bars¼ 80 mm.
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Supplementary Figure S1b online), or with anti-FLAG and
anti-V5 antibodies (Figure 1c and Supplementary Figure S1c
online). The PND was found in the nucleus and cytoplasm
of HaCaT cells, as previously reported in other cell culture
systems (Pearton et al., 2002). A substantial portion of trans-
fected loricrin colocalized with endogenous PND protein
in both the cytoplasmic and nuclear compartments of HaCaT
cells (Figure 1b). Cells nucleofected with tagged PND and
loricrin constructs confirmed the colocalization of PND and
loricrin peptides in the cytoplasm and nucleus of HaCaT cells
(Figure 1c and Supplementary Figure S1c online).
We next nucleofected pFLAG467proF into HaCaT cells
and double-stained these nucleofected cells with anti-FLAG
antibody and anti-K10 antibody. PND and K10 colocalized
in both the cytoplasm and nucleus (Figure 1d). We double-
stained human skin with B1 antibody and anti-K10 mAb. The
PND and K10 colocalized in the cytoplasm of granular cells
and the lower cornified layers. We also double-stained Lor/
mouse skin with profilaggrin B1 antibody and anti-K10 mAb.
In the absence of loricrin, the PND and K10 colocalized in
the cytoplasm of granular cells and lower cornified layers
(Figure 1d).
In order to more precisely define the interaction between
PND and loricrin or between PND and K10, immunoelectron
microscopy was performed using normal human epidermis.
The A2 and B1 antibodies decorated keratohyalin granules
in the granular layer and showed considerable labeling of
the lower layers of stratum corneum. The PND and loricrin
colocalized at the perimeter of large keratohyalin granules
as well as within smaller, less electron-dense granules
(Figure 2a). K10 and PND colocalized at the periphery of
keratohyalin granules with K10 antibody labeling filaments
juxtaposed to keratohyalin (Figure 2b). In Lor/ mouse skin,
K10 and PND also colocalized at the periphery of profilag-
grin-containing F-granules (Figure 2c). Quantitative analysis
also confirmed these results.
Biochemical evidence for association of the profilaggrin
N-terminus with loricrin and K10
To identify proteins that interact with the PND, a mouse
epidermal cDNA library was screened using the complete
mouse profilaggrin N-terminus as bait. A total of 65 positive
clones were initially obtained from the Y2H screen that was
performed on histidine-deficient media containing 2.5mM
3-AT (3-amino 1,2,4-triazole). A total of 15 distinct clones
were positive by Y2H upon retesting after retransformation
of purified plasmid DNAs into yeast. Among the interacting
cDNAs/proteins were three CE or cytoskeletal proteins
identified as loricrin, K10, and a SPRR (small proline-rich
protein)-like protein that displays 95% identity to a SPRR10-
like protein (Figure 3 and Table 1a). The PND interacts with
the central glycine/serine-rich region of mouse loricrin,
whereas it interacts with a fragment of K10 that includes
most of the C-terminal tail domain and the distal portion of
the a-helical rod domain (Table 1a). K10 and the SPRR-like
protein interact strongly with the complete mouse profilag-
grin N-terminus whereas loricrin interacts more weakly.
However, loricrin associates strongly with the human and
mouse B domain alone (Figure 3 and Table 1b). None of the
yeast or human control proteins interacted with loricrin, K10,
or the SPRR-like protein under medium- or high-stringency
Y2H conditions. Notably, loricrin and the SPRR-like protein
interact with the B domain alone, whereas K10 only bound to
the complete mouse PND (Table 1b).
To confirm that loricrin associates with the PND, HaCaT
cells were nucleofected with pcDNA3.1/V5-His-loricrin and
pFLAG467proF. Nucleofected HaCaT cells were lysed in
precipitation assay buffer and soluble lysates incubated with
anti-FLAG antibody. Immunoblotting of precipitated proteins
demonstrated the presence of both PND, loricrin and K10,
indicating that PND associates with loricrin and K10 in vitro
(Figure 4a). A direct association between PND and loricrin
was probed in vitro by glutathione S-transferase (GST) pull-
down analysis using recombinant GST-PND. Similarly a
direct association between PND and K10 was probed in vitro
by GST pull-down analyses using recombinant GST-PND.
The results are indicative of specific protein–protein interac-
tions (Figure 4b).
Effect of PND knockdown on organotypic raft cultures
To further investigate the molecular role of the PND, we
conducted PND knockdown experiments in organotypic raft
cultures. The raft culture keratinocyte system infected with
pAxewit2-PNDsiRNA or pAxewit2 vector containing the
scrambled sequence was analyzed. Immunohistochemistry
revealed reduced expression of PND and filaggrin in raft
culture keratinocyte system infected with pAxewit2-PNDsiR-
NA (Figure 5a). Reduced number and size of keratohyalin
granules were observed in keratinocytes infected with
pAxewit2-PNDsiRNA adenovirus as measured by electron
microscopy (Figure 5b). Immunoblot analysis using B1
antibody revealed that the raft culture keratinocyte system
infected with pAxewit2-PNDsiRNA did not express PND
(Figure 5c). Immunoblot analysis using anti-K10 and anti-
loricrin antibodies revealed that raft culture keratinocyte
system infected with pAxewit2-PNDsiRNA expressed K10
and reduced amounts of loricrin, respectively (Figure 5c). We
examined the expression of profilaggrin, K10, and loricrin
mRNAs by real-time reverse-transcriptase–PCR. Profilaggrin
mRNA was suppressed to 5.4% of the levels in cells infected
with pAxewit2-PNDsiRNA. K10 mRNA was suppressed to
82.3% of the levels in infected cells. Loricrin mRNA was
suppressed to 4.6% of the levels in infected cells (Figure 5d).
The reason why loricrin mRNA was knocked down by the
PND small interfering RNA (siRNA) is not clear right now.
There may be off-target effect by their siRNA. Glycine and
serine content of CE was reduced in infected cells (Supple-
mentary Table S1 online).
DISCUSSION
It has previously been shown that the PND is cleaved from
profilaggrin during epidermal terminal differentiation, where
it localizes to both the nucleus and cytoplasm within
granular, transition, and cornified cells (Presland et al.,
1997; Ishida-Yamamoto et al., 1998; Pearton et al., 2002).
However, its potential role in keratinocyte differentiation and
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barrier formation is unknown. In this study we focused on the
interaction between the PND and loricrin. Using the Y2H
assay, immunoprecipitation experiment, and GST pull-down
analysis, we demonstrated that loricrin associates with the
PND, confirming immunofluorescence and immunoelectron
microscopy findings showing colocalization in epidermis and
transfected HaCaT cells. The PND also associates with K10, a
protein that functions both as a CE protein and cytoskeletal
intermediate filament protein (Kalinin et al., 2001).
The importance of calcium in regulating epidermal
differentiation in vitro has been recognized for many years
(Elias et al., 2002). Moreover, there is considerable evidence
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Figure 2. Profilaggrin N-terminal domain (PND) colocalized not only with loricrin (Lor) but also keratin 10 (K10). (a) Post-embedding immunoelectron
microscopy using LR White resin method for in vivo human skin. B1 antibody and guinea pig polyclonal anti-loricrin antibody were used and labeled with 20
and 10 nm immunogold, respectively. PND signals were decorated in the keratohyalin granules. Loricrin (Lor) labels were closely associated with PND signals
(arrows). (b) Post-embedding immunoelectron microscopy using LR White resin method for in vivo human skin. B1 antibody and mouse anti-K10 mAb were
used and labeled with 20 and 10nm immunogold, respectively. K10 labels were closely associated with PND signals (arrows). (c) Post-embedding
immunoelectron microscopy using LR White resin method for Lor/ mouse skin. B1 antibody and mouse anti-K10 mAb were used and labeled with 20 and
10nm immunogold, respectively. K10 labels were closely associated with PND signals (arrows). Quantitative analysis also confirmed these results.
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for epidermal calcium gradient in vivo, which is abrogated
by barrier disruption (Mauro et al., 1998). Profilaggrin is
processed by several calcium-regulated endoproteases to
generate two major products, filaggrin and the PND. S100
proteins are a family of low-molecular-weight proteins
characterized by two calcium-binding EF-hands (Deshpande
et al., 2000; Donato, 2001; Broome et al., 2003; Eckert et al.,
2004). It is well known that S100 proteins serve as calcium
sensors that, upon activation, regulate the subcellular
distribution and/or function of specific target proteins.
S100A2, a S100 family member, was shown to be expressed
in the cytoplasm and nucleus of normal human keratinocytes
and HaCaT cells (Deshpande et al., 2000; Zhang et al.,
2002). This distribution pattern is very similar to the PND.
Thus, the PND may act like an S100 protein in the
keratinocyte, and loricrin appears to be one target protein
of the PND; our results show that K10 is another target.
Cultured keratinocytes generally show both nuclear and
cytoplasmic staining of PND (Pearton et al., 2002). While
in vivo, staining of PND is mostly cytoplasmic (Presland
et al., 1997; Ishida-Yamamoto et al., 1998). In vivo, the
protein may be mostly in the form of profilaggrin, with the
PND attached to the rest of the protein. Thus, immunolabel-
ing is mostly cytoplasmic, especially at keratohyalin
granules. Only in transition cell, or very occasionally in
granular cells, nuclear labeling is seen (Ishida-Yamamoto
et al., 1998). This is presumably because the PND is removed
from the rest of the protein, allowing it to localize to the
nucleus. In HaCaT cells doubly nucleofected with
pFLAG467proF and pcDNA3.1/V5-His-loricrin, the protein
is not localized to keratohyalin granules but rather can
distribute between the cytoplasm and nucleus. In addition,
the lack of filaggrin domains in these short N-terminal
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Figure 3. Loricrin (Lor) interacts with the profilaggrin N-terminus in yeast.
Prey (AD-loricrin) and bait combinations were transformed into yeast and
grown on either (a) histidine, leucine, and typtophan (HLT)-deficient plates or
(b) HLT-deficient plates containing 10mM 3-amino 1,2,4-triazole (3-AT).
Fusion proteins consisting of GAL4 activation domain-loricrin interact with
various mouse (m) or human (h) profilaggrin N-terminus peptide (AB or B
domains alone), but not with human or mouse A domain alone, S100A2 (A2),
human p53, or a series of yeast complementary DNAs (cDNAs; DAD, ND80,
and RAD17) expressed as fusion protein with the GAL4 DNA-binding domain.
Table 1a. The mouse profilaggrin N-terminus interacts
with cornified envelope–associated proteins and
keratin 10 (K10)
Gene/
protein name
Genbank
no.
Number
of clones
obtained
Region
involved in
interaction
Strength of
interaction
with mouse AB2
Loricrin (LOR) NP_032534 1 109–388 (486)1 +
K10 (KRT10) P02535 1 410–566 (570)1 +++
SPRR10-like NP_079696 5 2–182 (182)1 +++
Abbreviation: SPRR, small proline-rich protein.
1Size of protein in amino acids.
2‘‘+’’ Indicates growth in the absence of histidine plus 2.5mM 3-amino
1,2,4-triazole (3-AT); ‘‘++’’ indicates growth in histidine-deficient media
plus 10mM 3-AT; ‘‘+++’’ indicates growth in histidine-deficient media
plus 20mM 3-AT.
Table 1b. Loricrin, K10, and the SPRR10-like protein
interact with the B domain of mouse profilaggrin
Gene/
protein name
Interacts
with mouse
proFG AB1
Interacts
with mouse
proFG B
Interacts
with mouse
proFG A
Interacts
with human
proFG AB or B
Loricrin (LOR) + ++  +++ (B)
K10 (KRT10) +++  
SPRR10-like +++ +++  ++ (AB)
Abbreviations: FG, filaggrin; K10, keratin 10; SPRR, small proline-rich
protein.
1See Table 1 for description of yeast two-hybrid (Y2H) assay conditions.
A2
B1
Lor
Lor
K10
K10
Input
Input
IP: FLAG
M
oc
k
M
oc
k
D
ou
bl
e 
nu
cle
of
ec
tio
n
Lo
r n
uc
le
of
ec
tio
n
In
 v
iv
o 
hu
m
an
 s
ki
n
Eluate
Eluate
Figure 4. Association of the profilaggrin N-terminus with loricrin and
keratin 10 (K10). (a) HaCaT cell were doubly nucleofected with
pFLAG467proF and pcDNA3.1/V5-His-loricrin. The cells were lysed and
processed for FLAG immunoprecipitation (IP) followed by A2, B1, loricrin
(Lor), and K10 immunoblotting (n¼ 4). The immunoprecipitates of FLAG
contained loricrin and K10. (b) Glutathione S-transferase (GST) pull-down
assays. GST-tagged profilaggrin N-terminal domain (PND) was immobilized
on glutathione beads and probed for an interaction with Lor and K10. Binding
of GST-tagged PND to loricrin or K10 was determined by immunoblot
analyses (n¼ 4).
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peptides means that the protein is not bound to keratin
filaments, and thus not restricted to the cytoplasm. Although
loricrin is also observed in the nucleus in doubly nucleo-
fected HaCaT cells, this may be because of the fact that
overexpressed loricrin exists in nucleus (Yoneda et al.,
2010a, 2010b). In HaCaT cells singly nucleofected with
pFLAG467proF, K10 is localized in nucleus. Initiation of
keratin filament assembly occurs at discrete sites on the
nuclear envelope and filaments grow from the nucleus
toward the cytoplasm (Albers and Fuchs, 1989). K10
molecules just before filament assembly may be transported
into the nucleus via PND in pFLAG467proF-transfected
HaCaT cells. The PND colocalized with K10 in both normal
human epidermis and Lor/ mouse skin. Both loricrin and
the B domain of PND have a very similar amino-acid
composition, consisting of quasi-repetitive, glycine-rich
peptide sequences termed glycine loops, which might
facilitate their protein–protein interaction (Backendorf and
Hohl, 1992).
Previously, it was proposed that S100 proteins produced
in keratinocytes could act as ‘‘envelope organizer proteins,’’
acting to shuttle CE precursors to the site of CE assembly
where transglutaminases crosslink the CE precursors
(Robinson et al., 1997; Eckert et al., 2004). Several S100
proteins including S100A7, A10, and A11 have been shown
to be transglutaminase substrates (Ruse et al., 2001). The
PND may be acting in a similar manner, acting to transport
loricrin, K10, and other proteins to the site of CE assembly.
Its Ca2þ -binding ability may help to promote the CE
crosslinking and assembly process (Presland et al., 1995).
Immunoelectron microscopy data with a profilaggrin A
domain antibody showing immunolabeling of CEs within
the stratum corneum suggested that at least part of the PND is
incorporated into CEs (Presland et al., 1997). Recently,
Okada et al. (2004) found that S100A1 also had chaperone
ability. They demonstrated that thermal aggregation of citrate
synthase, aldolase, glyceraldehyde-3-phosphate dehydroge-
nase, and rhodanase was inhibited by S100A1. S100A1 sup-
pressed aggregation of denatured substrate during the refolding
pathway. The chaperones can interact with various cytoplasmic
proteins nonspecifically, which contrasts with PND that has a
limited number of cytoplasmic and nuclear targets. It is of
interest that the chaperone Hsp27 (heat shock protein 27)
associates with filaggrin in a phosphorylation-dependent
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Figure 5. Expression of profilaggrin N-terminal domain (PND) is efficiently blocked by PND small interfering RNA (siRNA) in raft culture keratinocyte
system. (a) In the raft culture keratinocyte system infected with pAxewit2-PNDsiRNA, immunostaining intensity of PND and filaggrin was reduced. DAPI,
4,6-diamidino-2-phenylindole. (b) Histogram quantitating the keratohyalin granules. For quantitation of keratohyalin granules, randomly selected cells
were photographed and printed at a final magnification of 60,000. The numbers of keratohyalin granules in six different squares were counted. Sizes of
keratohyalin granules were also graded. This electron microscopic analysis revealed that both number and size of keratohyalin granules were reduced
in the raft culture keratinocyte system infected with pAxewit2-PNDsiRNA. (c) Immunoblot analysis using B1 antibody revealed that raft culture keratinocyte
system infected with pAxewit2-PNDsiRNA did not express PND. Immunoblot analysis using anti-K10 and anti-loricrin antibodies revealed that raft culture
keratinocytes infected with pAxewit2-PNDsiRNA expressed keratin 10 (K10) and reduced the amount of loricrin (Lor), respectively (n¼ 4). (d) Real-time reverse-
transcriptase–PCR (RT-PCR) analysis of the expression of profilaggrin, K10, and Lor mRNAs. Profilaggrin mRNA was suppressed to 5.4% of the levels in
cells infected with pAxewit2-PNDsiRNA. K10 mRNA was suppressed to 82.3% of the levels in infected cells. Lor mRNA was suppressed to 4.6% of the levels
in infected cells.
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manner and that Hsp27 is a component of keratohyalin
(O’Shaughnessy et al., 2007).
We knocked down PND in the raft cultures of human
keratinocytes by using an adenoviral siRNA approach.
Mildner et al. (2010) knocked down filaggrin and observed
loss of keratohyalin granules and impairment of lamellar
body formation in human organotypic cultures. Reduction of
glycine and serine content in CE from raft culture keratino-
cyte system infected with pAxewit2-PNDsiRNA may be due
to reduced amount of loricrin in CE. This result strongly
supports our chaperone hypothesis. The PND knockdown
experiments in the raft cultures showed a reduction in loricrin
protein levels but not K10. There may be other chaperones
except PND for K10. The reason why loricrin mRNA was
knocked down by the PND siRNA is not clear right now.
There may be off-target effect by their siRNA. The molecular
mechanism behind this observation is currently being
analyzed in our laboratory.
In summary, this study shows that PND interacts with both
loricrin and K10. Our results suggest that PND has a
chaperone-like function similar to that of some other
S100 proteins, and may play a role in the ordered assembly
of the CE.
MATERIALS AND METHODS
Cell culture and nucleofection
The culture of HaCaT cells was carried out as previously described
(Yoneda et al., 2004). HaCaT cells were nucleofected using the
Amaxa Cell Line Optimization Nucleofector Kit (Lonza, Walkers-
ville, MD) (Han et al., 2008). For nucleofection, 10 mg of loricrin in
the pcDNA3.1/V5-His vector or pFLAG467proF plasmid was used
(Presland et al., 1997; Yoneda et al., 2010a). Following trypsiniza-
tion for 10minutes, 4 106 cells were suspended in 100 ml of Cell
Line Nucleofector Solution V in an Amaxa-certified cuvette. The
solution was then pulsed with the appropriate program U-20.
Immediately following pulsation, 500 ml of prewarmed DMEM was
added to each cuvette. The cells were transferred to a 1.5-ml
Eppendorf tube and incubated at 37 1C. After 10minutes, the
nucleofected cells were transferred to a 100-mm culture dishes
containing fresh, prewarmed DMEM and maintained at 37 1C.
At 48 hours after nucleofection, cells were collected for further
analysis. In each experiment, nucleofection efficiency was con-
firmed to be similar among different nucleofected plasmids using
X-gal staining (Yoneda et al., 2004).
Primary antibodies and reagents
The anti-V5 antibody was purchased from Life Technologies
(Carlsbad, CA), the anti-cytokeratin 10 antibody from DAKO
(Glostrup, Denmark), the mouse monoclonal anti-filaggrin (AKH1:
sc-66192) from Santa Cruz Biotechnology (Santa Cruz, CA), and the
mouse monoclonal anti-FALG (F1804) and the rabbit polyclonal
anti-FLAG (F7425) antibodies from Sigma-Aldrich (St Louis, MO).
The profilaggrin N-terminal antibodies A2 and B1 (to human
profilaggrin) were previously described (Presland et al., 1997;
Pearton et al., 2002). A peptide with the N-terminal 20 amino acids
of human loricrin (SYQKKQPTPQPPVDCVKTSG) was synthesized.
This peptide covalently coupled to keyhole limpet hemocyanin was
used to immunize guinea pigs and mice. Guinea pig antiserum was
affinity purified using a peptide affinity column. Mice were
immunized intraperitoneally with the above immunogen. At 3 days
after the final injection, the lymph nodes were removed and the
lymphocytes were fused with mouse P3 myeloma cells. The clones
that produced antibodies specifically recognized the human loricrin
were expanded.
Loricrin knockout mice
We isolated the mouse loricrin gene from a 129/Sv mouse genomic
library and made loricrin knockout mice as previously described
(Koch et al., 2000). To minimize phenotype variation due to the
mixed (129/Sv and C57Bl/6) genetic background, we crossed the
loricrin knockout mice into the FvB mouse strain. The experiments
described in this paper were performed using mice from the eighth
backcross.
Immunofluorescence microscopy
Normal human skin was obtained during plastic surgery procedures
with informed consent using protocols approved by the local
medical ethics committee that complies with the Declaration of
Helsinki Principles. Immunostaining was performed as described
previously (Yoneda et al., 1990a, 2004).
Immunoelectron microscopy
Normal human skin was obtained during plastic surgery procedures
with informed consent using protocols approved by the local
medical ethics committee that complies with the Declaration of
Helsinki Principles. Skin samples were taken from newborn
loricrin/ mice and diced with a scalpel into blocks of 1–2mm
square immediately after killing. These samples were immediately
fixed and prepared for immunoelectron microscopy using LR White.
Specimens were examined and images were recorded in a
JEM-1200EX (JEOL, Akishima, Japan). Quantitative analysis was
performed as described previously (Yoneda et al., 1990b).
Mouse profilaggrin constructs and Y2H assays
The complete mouse profilaggrin N-terminus that was used as a bait
for the Y2H screen was prepared by PCR (forward, 50-CCCGAATTC
TCCGCTCTCCTGGAAAGCATCACTAG-30 and reverse, 50-CCCGG
ATCCTTACCTGGATCTCCTCTGGTCAGCC-30) using a mouse pro-
filaggrin cDNA clone as template. The PCR product was digested
with the enzymes EcoRI and BamHI (underlined in PCR primers) and
cloned into pOBD, downstream and in-frame with the GAL4 DNA-
binding domain. The individual mouse profilaggrin A domain
(amino acids 1–99) and B domain (residues 99–283) constructs were
prepared by PCR and cloned into pOBD, downstream and in-frame
with the GAL4 DNA-binding domain. Individual human profilaggrin
A and B domain comprised amino acids 1–98 and 99–293,
respectively, expressed as GAL4 DNA-binding domain fusion
proteins in pOBD. The p53 and SV40 T-antigen constructs were
purchased from Clontech (Palo Alto, CA). The Y2H screens were
performed with a mouse epidermal cDNA library prepared in the
vector pGADT7 (obtained from Dr M Morasso, NIAMS, National
Institutes of Health, Bethesda, MD) using the complete mouse
profilaggrin N-terminus as bait. Plasmids were transformed into
Saccharomyces cerevisiae strain PJ694A (Yeast Resource Center,
University of Washington, Seattle, WA) using a commercial yeast
transformation kit (Zymo Research, Orange, CA). For the screen,
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B1 106 transformants were grown at 30 1C on 15-cm YPD plates
lacking histidine, leucine, and typtophan and containing 2.5mM 3-
AT (Sigma-Aldrich). Positive clones were rescued from yeast by first
growing on leucine-deficient plates and then in YPDA media to
isolate plasmid DNA (Zymoprep, Zymo Research). Plasmid DNA
was transformed into competent MH4 E. coli cells and miniprep
DNA isolated from 1–3 individual colonies for restriction digestion
and DNA sequencing. The identity of each cDNA clone was
determined by BLAST (Basic Local Alignment Search Tool, Bethesda,
MD) searches of the NCBI (National Center for Biotechnology
Information) database. Only cDNAs that were in-frame with upstream
GAL4 activation domain of pGADT7 were further considered.
Further analyses (‘‘retests’’) of each positive clone was performed
against the profilaggrin N-terminus (also individual A and B domain
constructs) and a panel of negative controls including a series of
S. cerevisiae cDNAs (ASK, DAD4, DUO1, NDC80, RAD17, SWN1;
provided by Dr S Fields, University of Washington), human S100A2,
and human p53 (Hudson et al., 1997). These results were generally
done with histidine, leucine, and typtophan plates containing
2.5–20mM 3-AT.
Immunoprecipitation and immunoblot analysis
Immunoprecipitation and immunoblot analysis was performed as
described previously (Yoneda et al., 2004). The proteins were
detected using an enhanced chemiluminescence system (GE
Healthcare Bio-Biosciences, Piscataway, NJ) according to the
manufacturer’s instructions.
GST pull-down
GST-PND was coupled to glutathione agarose (GE Healthcare Bio-
Biosciences) according to the manufacturer’s instructions, and cell
extract was added and incubated for 2 hours at 4 1C. Proteins were
eluted in SDS-PAGE buffer and analyzed by immunoblot analysis.
Preparation of the recombinant adenoviral vectors
The target sequences for PND siRNA oligonucleotides were
designed by siRNA Design Support System (Takara Bio, Otsu,
Japan) (Miyake et al., 1996; Dai et al., 2010). The oligo-
nucleotide containing the siRNA target sequence for human PND
(50-CTATGACACCACTGATAGT-30) and the appropriate restriction
sites was synthesized and inserted into pBAsi-hU6 Neo (Takara Bio).
This vector was designated as pBAsi-hU6 Neo PNDsiRNA. Control
vector was constructed through the same procedure using a scram-
bled sequence (50-GATCCGTCTTAATCGCGTATAAGGCTAGTGCT
CCTGGTTGGCCTTATACGCGATTAAGACTTTTTTA-30), which has a
nucleotide composition close to that of the PND target sequence. A
fragment containing the H1 promoter and the inserted sequence (H1
promoter-PND) was then excised by EcoRV digestion and ligated into
the pAxcwit2 vector. For production of adenoviruses, the packaging
cell line (human embryonic kidney (HEK) 293 cells) was maintained
in DMEM supplemented with 10% fetal bovine serum and the
appropriate antibiotics. At 1 day before transfection, cells were
seeded onto plates containing 4 106 cells per plate and incubated
in an atmosphere of 5% CO2 at 37 1C. pAxewit2-PNDsiRNA and
pAxewit2 vector of scrambled sequence were linearized with
BspT104I and transfected into the cells using TransIT-293 (Takara
Bio) according to the protocol. At 6 hours after transfection, fresh
growth medium was added to the cells. After 1 day, the cells were
spread in three 96-well plates in a 10-fold serial dilution mixed
with untransfected HEK293 cells. After being maintained in
culture for 10–15 days, virus clones were isolated and propagated
further to assess restriction analysis. The method used to
propagate adenovirus was as described (Miyake et al., 1996).
The raft culture keratinocyte system was constructed according to
Mildner et al. (2010).
Quantitative real-time reverse-transcriptase–PCR
Total RNA was isolated from control raft cultured keratinocyte and
raft cultured keratinocyte infected with pAxewit2-PNDsiRNA using
FastPure RNA Kit (Takara Bio). For reverse transcription, 25 ng of
total RNA from each sample was used as a template in a 10 ml
reaction system containing random primers and PrimeScript RT
Enzyme Mix I (Takara Bio). Reverse transcription reactions were
conducted at 37 1C for 15minutes and then inactivated at
95 1C for 5minutes. Quantitative real-time PCR was performed
using one step SYBR PrimeScript RT-PCR Kit II (Perfect Real Time).
The reaction volume was 25 ml, which included cDNA and SYBR
Premix Ex Taq (Takara Bio) as well as 10 mM PCR forward primer and
10 mM PCR reverse primer. Reactions were performed at 95 1C for
10 seconds followed by 40 cycles at 95 1C for 5 seconds and 60 1C
for 30 seconds. Each experiment was repeated two times. Glycer-
aldehyde-3-phosphate dehydrogenase was used as an internal
control for the relative quantification of target genes using the
comparative threshold cycle method.
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